Clinical Trial Details
EORTC-18021
Back to Clinical Trials Database
Intravenous versus intra-arterial fotemustine chemotherapy in patients with liver metastases from uveal melanoma : a randomized phase III study of the EORTC Melanoma Group.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 28-Jan-2005 Date Step1 close: 08-Jun-2011 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 262 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00110123 |
| NCT number | NCT00110123 |
| EudraCT | 2004-002245-12 |
